Results 141 to 150 of about 452,167 (205)

Experiences of disease-modifying treatments in patients with multiple sclerosis - a qualitative study. [PDF]

BMC Neurol
Gottberg K, Kierkegaard M, Larsson BJ, Ytterberg C.   +3 more
europepmc   +1 more source

Platelets During Myelin Repair in Multiple Sclerosis: Friend or Foe? [PDF]

J Neurochem
Rivera FJ, Philp AR, Reyes CR, Valenzuela-Krugmann C, Silva ME.   +4 more
europepmc   +1 more source

Role of isoflavones in multiple sclerosis. [PDF]

IBRO Neurosci Rep
Anushya Vardhini V, Sowmiya S, Abdul Sameer S, Sakthi R, Divya R, Monisha A.   +5 more
europepmc   +1 more source

Trans-orbital sonography of the optic nerve in multiple sclerosis. [PDF]

PLoS One
Tabatabaee S, Eissazade N, Mirzaasgari Z, Tabatabaee SM, Raeesmohammadi L, Motamed MR.   +5 more
europepmc   +1 more source

Chronic Pain in Multiple Sclerosis: Mechanisms, Clinical Characteristics and Treatment Strategies. [PDF]

Int J Mol Sci
Gklinos P, Christodoulou G, Pournara D, Evangelopoulos ME, Mitsikostas DD.   +4 more
europepmc   +1 more source

Mediterranean diet and risk of multiple sclerosis: A prospective cohort study. [PDF]

Mult Scler
Ratti S, Eke H, Cantarutti A, Bonn SE, Adami HO, Ye W, Ponzano M, Grotta A, Trolle Lagerros Y.   +8 more
europepmc   +1 more source

Circulating immune cells and risk of multiple sclerosis: A Mendelian randomization analysis. [PDF]

Medicine (Baltimore)
Zhou H, Yang X, Huang T.
europepmc   +1 more source

Multiple sclerosis and the risk of dementia: a real-world, nationwide cohort study. [PDF]

Front Neurol
Chen TA, Li ST, Chien WC, Chung CH, Wan FJ, Yeh TC, Yeh YW, Tzeng NS.   +7 more
europepmc   +1 more source

Hyperprolactinemia as a manifestation of multiple sclerosis attack. [PDF]

BMJ Neurol Open
Golparvar S, Naghavi S, Adibi I.
europepmc   +1 more source